Concepedia

Author

Jean-Marie Lang

Hôpitaux Universitaires de Strasbourg

Also Known As

J M Lang, J. -M. Lang, J. M. A. Lang, J. M. Lang, J.-M. Lang, J.M Lang, J.M. Lang, JEAN-MARIE LANG, Jean-Marie Lang, Jia Lang

104

Publications

4K

Citations

28

H-Index

61

Concepts

All Affiliations

Hôpitaux Universitaires de StrasbourgInsermInstitut de VirologieHôpital d'HautepierreHôpital Civil, Strasbourg
JL

About

Jean-Marie Lang is an author at Hôpitaux Universitaires de Strasbourg specializing in medicine, immunology, and hiv.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

24

1.4K

2

Public Health

2

2

34

3

Cell Biology

2

2

41

4

Health Sciences

1

1

29

5

Cellular Physiology

1

1

11

Jean-Marie Lang

×

43

Publications

3.7K

Citations

25

H-Index

YearCitations

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy

T Saint-Marc, M Partisani, Isabelle Poizot-Martin,

AIDS

1999

594

Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study

Marguerite Guiguet, François Boué, J. Cadranel,

The Lancet Oncology

2009

549

Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO* study

T Saint-Marc, M Partisani, Isabelle Poizot‐Martin,

AIDS

2000

360

Incidence of Non–AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus–Infected Patients

Magid Herida, Murielle Mary‐Krause, R. Kaphan,

Journal of Clinical Oncology

2003

337

High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV

B. Cribier, David Rey, Carine Schmitt,

AIDS

1995

232

Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load

David Rey, Véronique Krantz, Marialuisa Partisani,

Vaccine

2000

218

Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV

Sophie Grabar, Isabelle Kousignian, A Sobel,

AIDS

2004

186

Health-Related Quality of Life After 1 Year of Highly Active Antiretroviral Therapy

Patrizia Carrieri, Bruno Spire, Ségolène Duran,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2003

133

Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus--Infected Patients

Geneviève Chêne, E. Angelini, Laurent Cotte,

Clinical Infectious Diseases

2002

111

Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study

P. Dufour, Jean-Marie Lang, C. Giron,

Biotherapy

1993

86

Page 1